We create therapeutics platforms designed for needle-free, oral delivery of complex molecules and targeted drug delivery to the GI tract.
At Biora, we envision a world where patients have access to needle-free drug delivery and better therapeutic outcomes.
Investor insights
Funding rounds participated in
$3M sweet spot round size
Investor type
Public Company
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Funding rounds raised
Total raised
$3M
from investors over 1 rounds
B
Biora Therapeutics raised $3M on November 29, 2024